A new trading day began on Tuesday, with Agenus Inc (NASDAQ: AGEN) stock price up 24.24% from the previous day of trading, before settling in for the closing price of $2.31. AGEN’s price has ranged from $1.38 to $19.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 30.58%. Meanwhile, its annual earnings per share averaged 63.34%. With a float of $24.65 million, this company’s outstanding shares have now reached $25.31 million.
Let’s determine the extent of company efficiency that accounts for 316 employees. In terms of profitability, gross margin is 23.94%, operating margin of -116.44%, and the pretax margin is -223.75%.
Agenus Inc (AGEN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Agenus Inc is 2.60%, while institutional ownership is 32.04%.
Agenus Inc (AGEN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.07% during the next five years compared to 7.90% growth over the previous five years of trading.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Here are Agenus Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.69, a number that is poised to hit -1.65 in the next quarter and is forecasted to reach -3.26 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Looking closely at Agenus Inc (NASDAQ: AGEN), its last 5-days average volume was 1.4 million, which is a jump from its year-to-date volume of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 82.46%. Additionally, its Average True Range was 0.28.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 53.79%, which indicates a significant decrease from 77.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 153.35% in the past 14 days, which was higher than the 102.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.26, while its 200-day Moving Average is $4.35. However, in the short run, Agenus Inc’s stock first resistance to watch stands at $3.35. Second resistance stands at $3.84. The third major resistance level sits at $4.37. If the price goes on to break the first support level at $2.33, it is likely to go to the next support level at $1.80. Now, if the price goes above the second support level, the third support stands at $1.31.
Agenus Inc (NASDAQ: AGEN) Key Stats
With a market capitalization of 72.63 million, the company has a total of 25,309K Shares Outstanding. Currently, annual sales are 103,460 K while annual income is -227,210 K. The company’s previous quarter sales were 26,840 K while its latest quarter income was -45,860 K.
